查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1381603

免疫測量市場：按類型、產品類型、應用、最終用戶分類 - 全球預測 2023-2030

Radioimmunoassays Market by Type (Coated-Tube RIA, Double-Antibody RIA), Product Type (Analyzers, Reagents & Kits), Application, End-User - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

免疫測量市場預計將從 2022 年的 4.3039 億美元增至 2030 年的 6.12 億美元，預測期內年複合成長率為 4.49%。

全球免疫測量分析市場

主要市場統計
市場金額：基準年 [2022] 43039萬美元
預計市場金額[2023] 44894萬美元
預計市場金額[2030]6.120億美元 6.12 億美元
年複合成長率（%） 4.49%
放射免疫分析市場-IMG1

FPNV定位矩陣

FPNV定位矩陣是評估免疫測量市場的重要工具。透過分析與業務策略和產品滿意度相關的關鍵指標來全面評估供應商。這使得使用者能夠根據自己的具體資訊做出明智的決策。進階分析將供應商分為四個像限，每個象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。這個富有洞察力的框架使決策者能夠充滿信心地駕馭市場。

市場佔有率分析

市場佔有率分析為供應商的市場形勢提供了寶貴的見解。評估對整體收益、客戶群和其他關鍵指標的影響可以全面了解公司的業績及其面臨的競爭環境。該分析還揭示了研究期間的競爭水平，例如市場佔有率成長、碎片化、主導地位和行業整合。

該報告對以下幾個方面提供了寶貴的見解：

1.市場滲透：提供有關市場動態和主要企業產品的全面資訊。

2. 市場開拓：詳細分析新興和成熟細分市場的滲透情況，以突顯利潤豐厚的商機。

3. 市場多元化：有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：對未來技術、研發活動和突破性產品開發的智慧洞察。

本報告解決了以下關鍵問題：

1.免疫測量市場的市場規模與預測為何？

2.免疫測量市場中哪些產品、細分市場、應用和領域具有最高的投資潛力？

3.免疫測量市場的競爭策略窗口是什麼？

4.免疫測量市場的最新技術趨勢和法律規範是什麼？

5.免疫測量市場主要廠商的市場佔有率是多少？

6. 進入免疫測量市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 慢性疾病和感染疾病的傳播
      • 全球影像中心數量不斷增加
      • 快速轉向早期診斷和醫療費用飆升
    • 抑制因素
      • 對放射性物質保存期限短和危險的擔憂
    • 機會
      • 政府對生命科學研究活動的資助快速增加
      • 整合先進技術進行疾病診斷
    • 任務
      • 存在替代的先進免疫測量且缺乏熟練的專業人員
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 免疫測量市場：依類型

  • 塗層管RIA
  • 雙抗體放射免疫分析

第7章 免疫測量市場：依產品類型

  • 分析儀
  • 試劑和試劑盒

第8章 免疫測量市場：依應用分類

  • 臨床診斷
  • 調查

第9章 免疫測量市場：依最終用戶分類

  • 學術研究所
  • 臨床診斷實驗室
  • 醫院
  • 製藥和 CRO

第10章 美洲免疫測量市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太放射免疫測量市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲免疫測量市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • Abbexa Limited
    • Abcam Plc
    • ALPCO
    • Antigenix America, Inc.
    • Berthold Technologies GmbH & Co.KG
    • Biosynth Ltd
    • BioVendor-Laboratorni medicina as
    • Creative Biomart, Inc.
    • Danaher Corporation
    • Demeditec Diagnostics GmbH
    • Diasorine SPA
    • DRG International, Inc. by BioCheck Inc.
    • Drive DeVilbiss International
    • EUROIMMUN Medizinische Labordiagnostika AG
    • Hidex Oy.
    • IBL International GmbH
    • Immuno-Biological Laboratories, Inc.
    • Institute of Isotopes Co. Ltd.
    • LKB Instruments
    • LubioScience GmbH
    • Marin Biologic Laboratories, Inc.
    • Merck & Co, Inc
    • Montreal Biotech Inc.
    • MP Biomedicals, LLC
    • NovoLytix GmbH
    • Padyab Teb Co.
    • PerkinElmer Inc.
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-C002B1C99654

The Radioimmunoassays Market is projected to reach USD 612.00 million by 2030 from USD 430.39 million in 2022, at a CAGR of 4.49% during the forecast period.

Global Radioimmunoassays Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 430.39 million
Estimated Year Value [2023] USD 448.94 million
Forecast Year Value [2030] USD 612.00 million
CAGR (%) 4.49%
Radioimmunoassays Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Radioimmunoassays Market.

Based on Type, market is studied across Coated-Tube RIA and Double-Antibody RIA. The Double-Antibody RIA is projected to witness significant market share during forecast period.

Based on Product Type, market is studied across Analyzers and Reagents & Kits. The Reagents & Kits is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical Diagnostics and Research. The Research is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research Institutes, Clinical Diagnostic Laboratories, Hospitals, and Pharmaceuticals & CROs. The Academic & Research Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Radioimmunoassays Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Radioimmunoassays Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Radioimmunoassays Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam Plc, ALPCO, Antigenix America, Inc., Berthold Technologies GmbH & Co.KG, Biosynth Ltd, BioVendor - Laboratorni medicina a.s., Creative Biomart, Inc., Danaher Corporation, Demeditec Diagnostics GmbH, Diasorine S.P.A., DRG International, Inc. by BioCheck Inc., Drive DeVilbiss International, EUROIMMUN Medizinische Labordiagnostika AG, Hidex Oy., IBL International GmbH, Immuno-Biological Laboratories, Inc., Institute of Isotopes Co. Ltd., LKB Instruments, LubioScience GmbH, Marin Biologic Laboratories, Inc., Merck & Co, Inc, Montreal Biotech Inc., MP Biomedicals, LLC, NovoLytix GmbH, Padyab Teb Co., and PerkinElmer Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Radioimmunoassays Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Radioimmunoassays Market?

3. What is the competitive strategic window for identifying opportunities in the Radioimmunoassays Market?

4. What are the latest technology trends and regulatory frameworks in the Radioimmunoassays Market?

5. What is the market share of the leading vendors in the Radioimmunoassays Market?

6. Which modes and strategic moves are suitable for entering the Radioimmunoassays Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Radioimmunoassays Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic and infectious disease
      • 5.1.1.2. Increasing number of imaging centers across the globe
      • 5.1.1.3. Rapid shift towards early diagnosis and surge in healthcare expenditure
    • 5.1.2. Restraints
      • 5.1.2.1. Short shelf life and associated hazards concern with radioactive materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in government funding for life science research activity
      • 5.1.3.2. Integration of advanced technology for disease diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative advanced immunoassays and the dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Radioimmunoassays Market, by Type

  • 6.1. Introduction
  • 6.2. Coated-Tube RIA
  • 6.3. Double-Antibody RIA

7. Radioimmunoassays Market, by Product Type

  • 7.1. Introduction
  • 7.2. Analyzers
  • 7.3. Reagents & Kits

8. Radioimmunoassays Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Diagnostics
  • 8.3. Research

9. Radioimmunoassays Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Clinical Diagnostic Laboratories
  • 9.4. Hospitals
  • 9.5. Pharmaceuticals & CROs

10. Americas Radioimmunoassays Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Radioimmunoassays Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Radioimmunoassays Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbexa Limited
    • 14.1.2. Abcam Plc
    • 14.1.3. ALPCO
    • 14.1.4. Antigenix America, Inc.
    • 14.1.5. Berthold Technologies GmbH & Co.KG
    • 14.1.6. Biosynth Ltd
    • 14.1.7. BioVendor - Laboratorni medicina a.s.
    • 14.1.8. Creative Biomart, Inc.
    • 14.1.9. Danaher Corporation
    • 14.1.10. Demeditec Diagnostics GmbH
    • 14.1.11. Diasorine S.P.A.
    • 14.1.12. DRG International, Inc. by BioCheck Inc.
    • 14.1.13. Drive DeVilbiss International
    • 14.1.14. EUROIMMUN Medizinische Labordiagnostika AG
    • 14.1.15. Hidex Oy.
    • 14.1.16. IBL International GmbH
    • 14.1.17. Immuno-Biological Laboratories, Inc.
    • 14.1.18. Institute of Isotopes Co. Ltd.
    • 14.1.19. LKB Instruments
    • 14.1.20. LubioScience GmbH
    • 14.1.21. Marin Biologic Laboratories, Inc.
    • 14.1.22. Merck & Co, Inc
    • 14.1.23. Montreal Biotech Inc.
    • 14.1.24. MP Biomedicals, LLC
    • 14.1.25. NovoLytix GmbH
    • 14.1.26. Padyab Teb Co.
    • 14.1.27. PerkinElmer Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. RADIOIMMUNOASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. RADIOIMMUNOASSAYS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. RADIOIMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. RADIOIMMUNOASSAYS MARKET DYNAMICS
  • FIGURE 7. RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 8. RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 10. RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 14. RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. RADIOIMMUNOASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. RADIOIMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. RADIOIMMUNOASSAYS MARKET SIZE, BY COATED-TUBE RIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. RADIOIMMUNOASSAYS MARKET SIZE, BY DOUBLE-ANTIBODY RIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. RADIOIMMUNOASSAYS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. RADIOIMMUNOASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. RADIOIMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICALS & CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 188. RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 189. RADIOIMMUNOASSAYS MARKET LICENSE & PRICING